McMaster University
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, McMaster University sits in the top decile of US sponsors by registered trial count (#526 of 15,742 sponsors by registered trial count).
McMaster University: 31 sponsored US clinical trials, 4 recruiting.
McMaster University sponsors 31 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 21 completed. 10 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Critical Care, with 2 trials.
Top-decile sponsor footprint
McMaster University ranks in the top decile of sponsors by registered trial count (#526 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
21 of 23 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
31 total, page 1 of 1
Ketone Monoester Supplements, High Altitude, and Brain Blood Flow During Exercise
NCT07063732
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
NCT06957366
Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)
NCT06844227
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
NCT03127631
Treat & Extend Versus Fixed Dosing with Faricimab for Management of Diabetic Macular Edema: a Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial
NCT05610319
Surveillance AFter Extremity Tumor surgerY
NCT03944798
CYCLE: A Randomized Clinical Trial of Early In-bed Cycling for Mechanically Ventilated Patients
NCT03471247
Antireflux Surgery Without Preoperative Esophageal Manometry
NCT07659080
Cognitive Behavioural Therapy to Optimize Post-Operative Recovery Trial
NCT04274530
Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial
NCT03374800
Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal Resection
NCT03115541
Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial
NCT02462590
CYCLE Pilot Randomized Trial
NCT02377830
Fixation Using Alternative Implants for the Treatment of Hip Fractures (FAITH-2)
NCT01908751
Perioperative Anticoagulant Use for Surgery Evaluation Study
NCT02228798
Detection and Neurological Impact of CerebroVascular Events In Noncardiac Surgery PatIents: A COhort EvaluatioN
NCT01980511
HIP Fracture Accelerated Surgical TreaTment And Care tracK (HIP ATTACK) Trial
NCT02027896
Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT): A Feasibility Clinical Trial
NCT01782755
Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY)
NCT01479283
Comparison of Platelet Rich Plasma and Alternative Therapies for the Treatment of Tennis Elbow (Lateral Epicondylitis)
NCT01668953
Nurse-family Partnership (NFP) Curriculum Study
NCT01372098
Remote Ischemic Preconditioning in Cardiac Surgery Trial
NCT01071265
Chalazion Conservative Treatment Trial
NCT01230593
Comparing Total Hip Arthroplasty and Hemi-Arthroplasty on Secondary Procedures and Quality of Life in Adults With Displaced Hip Fractures
NCT00556842
D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months
NCT00720915
Nasal Intermittent Positive Pressure Ventilation in Premature Infants (NIPPV)
NCT00433212
Canadian Oxygen Trial (COT)
NCT00637169
Fluid Lavage of Open Wounds (FLOW): Pilot Trial
NCT01069315
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)
NCT00182143
Premature Infants in Need of Transfusion (PINT)
NCT00182390
Caffeine for Apnea of Prematurity (CAP)
NCT00182312
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 8 |
| Phase 4 | 2 |
Therapeutic Areas
Where McMaster University enrollment is open (later-stage tilt)
4 recruiting of 31 indexed (13% open); 21 completed (68%).
Phase mix: 10 late (III/IV) vs 2 early (I/II) (later-stage heavy).
Top condition: Critical Care (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
McMaster University: open-pipeline peers nationwide
Peers matched on 31 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
McMaster University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 31 trials (± recruiting share)
- Children's Hospitals and Clinics of Minnesota · 31 trials · 10% recruiting
- Cook Group Incorporated · 31 trials · 0% recruiting
- Cytokinetics · 31 trials · 10% recruiting
- Halozyme Therapeutics · 31 trials · 3% recruiting
Sponsors near 13% open enrollment (± trial volume)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · 13% recruiting · 93 trials
- Temple University · 13% recruiting · 163 trials
- University of Pittsburgh · 13% recruiting · 1,238 trials
- Intermountain Health Care · 13% recruiting · 85 trials
Related
What to do with this McMaster University page
31 registered trials is a research-attention snapshot, not an endorsement of McMaster University or any single study.
- 4 of McMaster University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Critical Care is the condition McMaster University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Critical Care trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
McMaster University pipeline card: 31 registered trials from official public datasets.Report a data error.